An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Catalent, Inc. to Present at September Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Catalent, Inc. (NYSE: CTLT) is set to participate in two investor conferences: the Morgan Stanley 20th Annual Global Healthcare Conference on September 13 at 11:45 a.m. ET, and the Baird’s 2022 Global Healthcare Conference on September 14 at 10:50 a.m. ET. A live webcast of these presentations will be available on their investor website, with replays following the events. Catalent is a global leader in optimizing product development and supply for pharma, biotech, and consumer health, generating nearly $5 billion in revenue in FY2022.
Positive
None.
Negative
None.
SOMERSET, N.J.--(BUSINESS WIRE)--
Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will participate at two upcoming investor conferences.
On September 13, 2022 at 11:45 a.m. ET, the Company will present at the Morgan Stanley 20th Annual Global Healthcare Conference.
On September 14, 2022, at 10:50 a.m. ET, the Company will present at Baird’s 2022 Global Healthcare Conference.
A live webcast of the presentation will be accessible at http://investor.catalent.com and will be available for replay following the event.
About Catalent Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.
Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 19,000 includes more than 3,000 scientists and technicians.
Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit www.catalent.com.
What is Catalent's participation in investor conferences in September 2022?
Catalent, Inc. will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 11:45 a.m. ET, and at Baird’s 2022 Global Healthcare Conference on September 14, 2022, at 10:50 a.m. ET.
Where can I watch the Catalent investor conference presentations?
The presentations will be available via a live webcast on Catalent's investor website at http://investor.catalent.com.
What is Catalent's revenue for fiscal year 2022?
Catalent, Inc. generated nearly $5 billion in revenue during its fiscal year 2022.
What services does Catalent provide?
Catalent, Inc. specializes in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and supply of better patient treatments across multiple modalities.
How many products does Catalent launch each year?
Catalent launches over 150 new products every year, supporting more than 1,000 partner programs.
